Dr. Bijan Salehezideh is a Co-Founder & serves as Managing Director at NaviMed Capital. Prior to co-founding NaviMed Capital, he was a General Partner at Highland Capital Partners, where he focused on growth-stage healthcare investments. Prior to Highland Capital Partners, he spent several years in a variety of healthcare operational roles at publicly traded and emerging growth companies. He led NaviMed's investments and currently, serves on the Board of Directors of Advantage Surgical & Wound Care and The CM Group. He also serves on the Board of Directors of OPN Healthcare, Aledade, and Lux Health Tech Acquisition Corp. He also has served on the Board of Directors of several companies including Auris Health, BARRX Medical, Hyperion Therapeutics, Lumere, and Opgen. In addition, he sourced or was actively involved in Highland Capital Partners' investments in AVEO, Baronova, Conor Medsystems, kyruus, and Pharmaca Integrative Pharmacy. He holds an AB in Molecular Biology from Princeton University, an MD and Master's in Science in Health Policy from Columbia University, and an MBA from Harvard Business School. He is also a graduate of the Kauffman Fellows Program.